128 related articles for article (PubMed ID: 27878296)
1. Pseudolaric acid B inhibits the secretion of hepatitis B virus.
Yu J; Wang Z; Ren P; Zhong T; Wang Y; Song F; Hou J; Yu X; Hua S
Oncol Rep; 2017 Jan; 37(1):519-525. PubMed ID: 27878296
[TBL] [Abstract][Full Text] [Related]
2. Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways.
Zhang H; Li JC; Luo H; Zhao L; Zhang ZD; Shen XF
Phytomedicine; 2019 Jun; 59():152759. PubMed ID: 31004883
[TBL] [Abstract][Full Text] [Related]
3. Effects of cell cycle on telomerase activity and on hepatitis B virus replication in HepG2 2.2.15 cells.
Huang YQ; Wang LW; Yan SN; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):543-7. PubMed ID: 15567742
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B Virus Deregulates the Cell Cycle To Promote Viral Replication and a Premalignant Phenotype.
Xia Y; Cheng X; Li Y; Valdez K; Chen W; Liang TJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021897
[TBL] [Abstract][Full Text] [Related]
5. S-phase arrest after vincristine treatment may promote hepatitis B virus replication.
Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL
World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769
[TBL] [Abstract][Full Text] [Related]
6. Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication.
Wang YC; Yang X; Xing LH; Kong WZ
World J Gastroenterol; 2013 Aug; 19(31):5159-64. PubMed ID: 23964152
[TBL] [Abstract][Full Text] [Related]
7. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
[TBL] [Abstract][Full Text] [Related]
8. ATM-p53 pathway causes G2/M arrest, but represses apoptosis in pseudolaric acid B-treated HeLa cells.
Yao G; Qi M; Ji X; Fan S; Xu L; Hayashi T; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2014 Sep; 558():51-60. PubMed ID: 24929187
[TBL] [Abstract][Full Text] [Related]
9. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
[TBL] [Abstract][Full Text] [Related]
10. Pseudolaric acid B inhibits neuroglioma cell proliferation through DNA damage response.
Song F; Yu X; Zhang H; Wang Z; Wang Y; Meng X; Yu J
Oncol Rep; 2017 Oct; 38(4):2211-2218. PubMed ID: 28765951
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
[TBL] [Abstract][Full Text] [Related]
12. High load hepatitis B virus replication inhibits hepatocellular carcinoma cell metastasis through regulation of epithelial-mesenchymal transition.
Wang T; Jin Y; Zhao R; Wu Y; Zhang Y; Wu D; Kong D; Jin X; Zhang F
Int J Infect Dis; 2014 Mar; 20():37-41. PubMed ID: 24412602
[TBL] [Abstract][Full Text] [Related]
13. Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis.
Kunanopparat A; Kimkong I; Palaga T; Tangkijvanich P; Sirichindakul B; Hirankarn N
World J Gastroenterol; 2016 Oct; 22(37):8361-8374. PubMed ID: 27729742
[TBL] [Abstract][Full Text] [Related]
14. [Pseudolaric acid B induces G2/M arrest and inhibits invasion and migration in HepG2 hepatoma cells].
Li S; Guo L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):59-64. PubMed ID: 29595459
[TBL] [Abstract][Full Text] [Related]
15. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
16. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
[TBL] [Abstract][Full Text] [Related]
17. Activation of p53 contributes to pseudolaric acid B-induced senescence in human lung cancer cells in vitro.
Yao GD; Yang J; Li Q; Zhang Y; Qi M; Fan SM; Hayashi T; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2016 Jul; 37(7):919-29. PubMed ID: 27041461
[TBL] [Abstract][Full Text] [Related]
18. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
19. Pseudolaric acid B exerts antitumor activity via suppression of the Akt signaling pathway in HeLa cervical cancer cells.
Li M; Hong L
Mol Med Rep; 2015 Aug; 12(2):2021-6. PubMed ID: 25891953
[TBL] [Abstract][Full Text] [Related]
20. miR-429 represses cell proliferation and induces apoptosis in HBV-related HCC.
Gao H; Liu C
Biomed Pharmacother; 2014 Oct; 68(8):943-9. PubMed ID: 25312821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
